ATH 33.3% 0.4¢ alterity therapeutics limited

nasdaq equivalent , page-12

  1. 181 Posts.
    No disagree! HD not a large enough market
    They need to get on with efficacy trials to prove AD breakthrough, if they can
    They don't have enough cash atm, however could raise
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.